Precision Fermentation Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	180 Pages	Fortune Business Insights Pvt. Ltd.	September, 2024	FOB19185788

Best Price Guarantee
Price	from $4,850
Length	180 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	September, 2024
SKU	FOB19185788

Precision Fermentation Market

Growth Factors of Precision Fermentation Market

The precision fermentation market size was valued at USD 2.14 billion in 2023, and the market is now projected to grow from USD 3.03 billion in 2024 to USD 57.01 billion by 2032, exhibiting a CAGR of 44.30% during the forecast period of 2024-2032.

The COVID-19 pandemic considerably impacted the marketplace's boom, leading to a surge in demand for proteins and protein-based food, and expanded investment in new startups, supporting research and protein improvement.

The use of precision formation technology for animal protein manufacturing is gaining interest due to environmental concerns about climate change and human contributing to global warming. The emission of greenhouse gases from animal farms is a primary motive of worldwide temperature increase, prompting a need to reduce harmful emissions and adopt opportunity food production strategies. The adoption of this technology is anticipated to propel precision fermentation market growth.

Companies like Change Foods are utilizing technology to growth the manufacturing of alternative proteins, because the demand for sustainable meals improvement will increase. In March 2023, Change Foods partnered with KEZAD Group to create animal-free casein milk proteins that may replace 10,000 cows, reducing reliance on animal farms and supporting sustainable meals production and sourcing.

Comprehensive Analysis of Precision Fermentation Market

Precision fermentation based totally on microbes is segmented into micro-organism, yeast, algae, and fungi. Yeast is the most not unusual microorganism used for generating whey and milk protein, heme protein, enzymes, and different substances. Bacteria account for dairy proteins, heme proteins, meals and drinks, and pharmaceutical merchandise. The marketplace is split into meat and seafood, dairy alternatives, egg options, processed meals and liquids, skin care, and haircare merchandise. Dairy options have the very best marketplace percentage, even as biopharmaceuticals use unique strains of microbes. Food and beverage have the very best market proportion.

The Europe region lead the precision fermentation market share by benefitting a market size of USD 1.06 billion in 2023 due to clients are transferring towards environmentally friendly meat options, with Europe main the way in figuring out and manufacturing animal proteins with much less pollutants and comparable texture and flavour. Germany, the U.K., and France are leading producers the usage of precision fermentation, and groups are investing in production abilities to satisfy the growing demand for opportunity proteins inside the region.

The precision fermentation marketplace is a developing industry with key players like The Every Co., Perfect Day Inc., Shiru Inc., and Geltor investing in protein research and improvement. The boom of this industry is supported by means of favourable regulatory rules in the U.S., Israel, and Singapore, along with no-objection letters from the U.S. Food and Drug Administration for egg and yeast protein merchandise.

Nestlé SA delivered its first precision fermentation-based totally dairy protein powder in February 2024, a whey isolate that is animal-free and lactose-unfastened, solidifying its function inside the useful nutrients market.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 44.30% from 2024 to 2032

Unit Value (USD Billion)

Segmentation By Microbe Type

- Bacteria

- Yeast

- Algae

- Fungi

By Ingredient

- Egg protein

- Heme protein

- Collagen protein

- Whey and Casein protein

- Enzymes

- Others

By Application

- Meat and Seafood

- Dairy Alternatives

- Egg Alternatives

- Processed food and beverages

- Skincare and haircare products

- Others

By End Use

- Food and Beverages

- Cosmetics

- Pharmaceuticals

By Region

- North America (U.S., Canada, and Mexico)

- Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe)

- Asia Pacific (China, India, Japan, Australia, Thailand, Singapore and Rest of Asia Pacific)

- South America (Brazil, Argentina, and Rest of South America)

- Middle East & Africa (Israel, UAE, and Rest of the Middle East & Africa)

Region

- North America (By Microbe Type, Ingredient, Application, End Use and Country)

U.S. (By End Use)
Canada (By End Use)
Mexico (By End Use)

- Europe (By Microbe Type, Ingredient, Application, End Use and Country)

U.K. (By End Use)
Germany (By End Use)
France (By End Use)
Spain (By End Use)
Italy (By End Use)
Rest of Europe (By End Use)

- Asia Pacific (By Microbe Type, Ingredient, Application, End Use and Country)

China (By End Use)
India (By End Use)
Japan (By End Use)
Australia (By End Use)
Thailand (By End Use)
Singapore (By End Use)
Rest of Asia Pacific (By End Use)

- South America (By Microbe Type, Ingredient, Application, End Use and Country)

Brazil (By End Use)
Argentina (By End Use)
Rest of South America (By End Use)

- Middle East & Africa (By Microbe Type, Ingredient, Application, End Use and Country)

Israel (By End Use)
UAE (By End Use)
Rest of MEA (By End Use)

Please Note:

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Overview on the Parent Market; 4.2. Supply Chain Analysis; 4.3. Qualitative Analysis on Technological Advancements; 4.4. Industry SWOT Analysis; 4.5. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches; 4.6. Market Analysis and Insights (in Relation with COVID-19)
5. Global Precision Fermentation Market Analysis, Insights and Forecast, 2019-2032: 5.1. Key Findings / Summary; 5.2. Market Size Estimates and Forecast; 5.2.1. By Microbe Type (Value); 5.2.1.1. Bacteria; 5.2.1.2. Yeast; 5.2.1.3. Algae; 5.2.1.4. Fungi; 5.2.2. By Ingredient (Value); 5.2.2.1. Egg protein; 5.2.2.2. Heme protein; 5.2.2.3. Collagen protein; 5.2.2.4. Whey and Casein protein; 5.2.2.5. Enzymes; 5.2.2.6. Others; 5.2.3. By Application (Value); 5.2.3.1. Meat and Seafood; 5.2.3.2. Dairy Alternatives; 5.2.3.3. Egg Alternatives; 5.2.3.4. Processed food and beverages; 5.2.3.5. Skincare and haircare products; 5.2.3.6. Others; 5.2.4. By End Use (Value); 5.2.4.1. Food and Beverages; 5.2.4.2. Cosmetics; 5.2.4.3. Pharmaceuticals; 5.2.5. By Region (Value); 5.2.5.1. North America; 5.2.5.2. Europe; 5.2.5.3. Asia Pacific; 5.2.5.4. South America; 5.2.5.5. Middle East & Africa
6. North America Precision Fermentation Market Analysis, Insights and Forecast, 2019-2032: 6.1. Key Findings / Summary; 6.2. Market Size Estimates and Forecast; 6.2.1. By Microbe Type (Value); 6.2.1.1. Bacteria; 6.2.1.2. Yeast; 6.2.1.3. Algae; 6.2.1.4. Fungi; 6.2.2. By Ingredient (Value); 6.2.2.1. Egg protein; 6.2.2.2. Heme protein; 6.2.2.3. Collagen protein; 6.2.2.4. Whey and Casein protein; 6.2.2.5. Enzymes; 6.2.2.6. Others; 6.2.3. By Application (Value); 6.2.3.1. Meat and Seafood; 6.2.3.2. Dairy Alternatives; 6.2.3.3. Egg Alternatives; 6.2.3.4. Processed food and beverages; 6.2.3.5. Skincare and haircare products; 6.2.3.6. Others; 6.2.4. By End Use (Value); 6.2.4.1. Food and Beverages; 6.2.4.2. Cosmetics; 6.2.4.3. Pharmaceuticals; 6.2.5. By Country (Value); 6.2.5.1. U.S.; 6.2.5.1.1. By End Use (Value); 6.2.5.1.1.1. Food and Beverages; 6.2.5.1.1.2. Cosmetics; 6.2.5.1.1.3. Pharmaceuticals; 6.2.5.2. Canada; 6.2.5.2.1. By End Use (Value); 6.2.5.2.1.1. Food and Beverages; 6.2.5.2.1.2. Cosmetics; 6.2.5.2.1.3. Pharmaceuticals; 6.2.5.3. Mexico; 6.2.5.3.1. By End Use (Value); 6.2.5.3.1.1. Food and Beverages; 6.2.5.3.1.2. Cosmetics; 6.2.5.3.1.3. Pharmaceuticals
7. Europe Precision Fermentation Market Analysis, Insights and Forecast, 2019-2032: 7.1. Key Findings / Summary; 7.2. Market Size Estimates and Forecast; 7.2.1. By Microbe Type (Value); 7.2.1.1. Bacteria; 7.2.1.2. Yeast; 7.2.1.3. Algae; 7.2.1.4. Fungi; 7.2.2. By Ingredient (Value); 7.2.2.1. Egg protein; 7.2.2.2. Heme protein; 7.2.2.3. Collagen protein; 7.2.2.4. Whey and Casein protein; 7.2.2.5. Enzymes; 7.2.2.6. Others; 7.2.3. By Application (Value); 7.2.3.1. Meat and Seafood; 7.2.3.2. Dairy Alternatives; 7.2.3.3. Egg Alternatives; 7.2.3.4. Processed food and beverages; 7.2.3.5. Skincare and haircare products; 7.2.3.6. Others; 7.2.4. By End Use (Value); 7.2.4.1. Food and Beverages; 7.2.4.2. Cosmetics; 7.2.4.3. Pharmaceuticals; 7.2.5. By Country (Value); 7.2.5.1. U.K.; 7.2.5.1.1. By End Use (Value); 7.2.5.1.1.1. Food and Beverages; 7.2.5.1.1.2. Cosmetics; 7.2.5.1.1.3. Pharmaceuticals; 7.2.5.2. France; 7.2.5.2.1. By End Use (Value); 7.2.5.2.1.1. Food and Beverages; 7.2.5.2.1.2. Cosmetics; 7.2.5.2.1.3. Pharmaceuticals; 7.2.5.3. Germany; 7.2.5.3.1. By End Use (Value); 7.2.5.3.1.1. Food and Beverages; 7.2.5.3.1.2. Cosmetics; 7.2.5.3.1.3. Pharmaceuticals; 7.2.5.4. Italy; 7.2.5.4.1. By End Use (Value); 7.2.5.4.1.1. Food and Beverages; 7.2.5.4.1.2. Cosmetics; 7.2.5.4.1.3. Pharmaceuticals; 7.2.5.5. Spain; 7.2.5.5.1. By End Use (Value); 7.2.5.5.1.1. Food and Beverages; 7.2.5.5.1.2. Cosmetics; 7.2.5.5.1.3. Pharmaceuticals; 7.2.5.6. Rest of Europe; 7.2.5.6.1. By End Use (Value); 7.2.5.6.1.1. Food and Beverages; 7.2.5.6.1.2. Cosmetics; 7.2.5.6.1.3. Pharmaceuticals
8. Asia Pacific Precision Fermentation Market Analysis, Insights and Forecast, 2019-2032: 8.1. Key Findings / Summary; 8.1.1. By Microbe Type (Value); 8.1.1.1. Bacteria; 8.1.1.2. Yeast; 8.1.1.3. Algae; 8.1.1.4. Fungi; 8.1.2. By Ingredient (Value); 8.1.2.1. Egg protein; 8.1.2.2. Heme protein; 8.1.2.3. Collagen protein; 8.1.2.4. Whey and Casein protein; 8.1.2.5. Enzymes; 8.1.2.6. Others; 8.1.3. By Application (Value); 8.1.3.1. Meat and Seafood; 8.1.3.2. Dairy Alternatives; 8.1.3.3. Egg Alternatives; 8.1.3.4. Processed food and beverages; 8.1.3.5. Skincare and haircare products; 8.1.3.6. Others; 8.1.4. By End Use (Value); 8.1.4.1. Food and Beverages; 8.1.4.2. Cosmetics; 8.1.4.3. Pharmaceuticals; 8.1.4.4. Others; 8.1.5. By Country (Value); 8.1.5.1. China; 8.1.5.1.1. By End Use (Value); 8.1.5.1.1.1. Food and Beverages; 8.1.5.1.1.2. Cosmetics; 8.1.5.1.1.3. Pharmaceuticals; 8.1.5.2. India; 8.1.5.2.1. By End Use (Value); 8.1.5.2.1.1. Food and Beverages; 8.1.5.2.1.2. Cosmetics; 8.1.5.2.1.3. Pharmaceuticals; 8.1.5.2.1.4. Others; 8.1.5.3. Japan; 8.1.5.3.1. By End Use (Value); 8.1.5.3.1.1. Food and Beverages; 8.1.5.3.1.2. Cosmetics; 8.1.5.3.1.3. Pharmaceuticals; 8.1.5.4. Australia; 8.1.5.4.1. By End Use (Value); 8.1.5.4.1.1. Food and Beverages; 8.1.5.4.1.2. Cosmetics; 8.1.5.4.1.3. Pharmaceuticals; 8.1.5.5. Thailand; 8.1.5.5.1. By End Use (Value); 8.1.5.5.1.1. Food and Beverages; 8.1.5.5.1.2. Cosmetics; 8.1.5.5.1.3. Pharmaceuticals; 8.1.5.6. Singapore; 8.1.5.6.1. By End Use (Value); 8.1.5.6.1.1. Food and Beverages; 8.1.5.6.1.2. Cosmetics; 8.1.5.6.1.3. Pharmaceuticals; 8.1.5.7. Rest of APAC; 8.1.5.7.1. By End Use (Value); 8.1.5.7.1.1. Food and Beverages; 8.1.5.7.1.2. Cosmetics; 8.1.5.7.1.3. Pharmaceuticals
9. South America Precision Fermentation Market Analysis, Insights and Forecast, 2019-2032: 9.1. Key Findings / Summary; 9.1.1. By Microbe Type (Value); 9.1.1.1. Bacteria; 9.1.1.2. Yeast; 9.1.1.3. Algae; 9.1.1.4. Fungi; 9.1.2. By Ingredient (Value); 9.1.2.1. Egg protein; 9.1.2.2. Heme protein; 9.1.2.3. Collagen protein; 9.1.2.4. Whey and Casein protein; 9.1.2.5. Enzymes; 9.1.2.6. Others; 9.1.3. By Application (Value); 9.1.3.1. Meat and Seafood; 9.1.3.2. Dairy Alternatives; 9.1.3.3. Egg Alternatives; 9.1.3.4. Processed food and beverages; 9.1.3.5. Skincare and haircare products; 9.1.3.6. Others; 9.1.4. By End Use (Value); 9.1.4.1. Food and Beverages; 9.1.4.2. Cosmetics; 9.1.4.3. Pharmaceuticals; 9.1.4.4. Others; 9.1.5. By Country (Value); 9.1.5.1. Brazil; 9.1.5.1.1. By End Use (Value); 9.1.5.1.1.1. Food and Beverages; 9.1.5.1.1.2. Cosmetics; 9.1.5.1.1.3. Pharmaceuticals; 9.1.5.2. Argentina; 9.1.5.2.1. By End Use (Value); 9.1.5.2.1.1. Food and Beverages; 9.1.5.2.1.2. Cosmetics; 9.1.5.2.1.3. Pharmaceuticals; 9.1.5.3. Rest of South America; 9.1.5.3.1. By End Use (Value); 9.1.5.3.1.1. Food and Beverages; 9.1.5.3.1.2. Cosmetics; 9.1.5.3.1.3. Pharmaceuticals
10. Middle East and Africa Precision Fermentation Market Analysis, Insights and Forecast, 2019-2032: 10.1. Key Findings / Summary; 10.1.1. By Microbe Type (Value); 10.1.1.1. Bacteria; 10.1.1.2. Yeast; 10.1.1.3. Algae; 10.1.1.4. Fungi; 10.1.2. By Ingredient (Value); 10.1.2.1. Egg protein; 10.1.2.2. Heme protein; 10.1.2.3. Collagen protein; 10.1.2.4. Whey and Casein protein; 10.1.2.5. Enzymes; 10.1.2.6. Others; 10.1.3. By Application (Value); 10.1.3.1. Meat and Seafood; 10.1.3.2. Dairy Alternatives; 10.1.3.3. Egg Alternatives; 10.1.3.4. Processed food and beverages; 10.1.3.5. Skincare and haircare products; 10.1.3.6. Others; 10.1.4. By End Use (Value); 10.1.4.1. Food and Beverages; 10.1.4.2. Cosmetics; 10.1.4.3. Pharmaceuticals; 10.1.5. By Country (Value); 10.1.5.1. Israel; 10.1.5.1.1. By End Use (Value); 10.1.5.1.1.1. Food and Beverages; 10.1.5.1.1.2. Cosmetics; 10.1.5.1.1.3. Pharmaceuticals; 10.1.5.2. UAE; 10.1.5.2.1. By End Use (Value); 10.1.5.2.1.1. Food and Beverages; 10.1.5.2.1.2. Cosmetics; 10.1.5.2.1.3. Pharmaceuticals; 10.1.5.3. Rest of ME&A; 10.1.5.3.1. By End Use (Value); 10.1.5.3.1.1. Food and Beverages; 10.1.5.3.1.2. Cosmetics; 10.1.5.3.1.3. Pharmaceuticals
11. Competitive Matrix: 11.1. Strategy Analysis; 11.2. Market Revenue Ranking Analysis, By Key Manufacturer
12. Company Profiles: 12.1. Perfect Day Inc.; 12.1.1. Overview; 12.1.2. Description; 12.1.3. Microbe Type Portfolio; 12.1.4. Financials (Data as available in public domain and/or on paid databases); 12.1.5. Recent Developments; 12.2. The Every Co.; 12.2.1. Overview; 12.2.2. Description; 12.2.3. Microbe Type Portfolio; 12.2.4. Financials (Data as available in public domain and/or on paid databases); 12.2.5. Recent Developments; 12.3. GELTOR; 12.3.1. Overview; 12.3.2. Description; 12.3.3. Microbe Type Portfolio; 12.3.4. Financials (Data as available in public domain and/or on paid databases); 12.3.5. Recent Developments; 12.4. Imagindairy Inc.; 12.4.1. Overview; 12.4.2. Description; 12.4.3. Microbe Type Portfolio; 12.4.4. Financials (Data as available in public domain and/or on paid databases); 12.4.5. Recent Developments; 12.5. Shiru Inc.; 12.5.1. Overview; 12.5.2. Description; 12.5.3. Microbe Type Portfolio; 12.5.4. Financials (Data as available in public domain and/or on paid databases); 12.5.5. Recent Developments; 12.6. Impossible Foods; 12.6.1. Overview; 12.6.2. Description; 12.6.3. Microbe Type Portfolio; 12.6.4. Financials (Data as available in public domain and/or on paid databases); 12.6.5. Recent Developments; 12.7. Change Foods; 12.7.1. Overview; 12.7.2. Description; 12.7.3. Microbe Type Portfolio; 12.7.4. Financials (Data as available in public domain and/or on paid databases); 12.7.5. Recent Developments; 12.8. Vivici; 12.8.1. Overview; 12.8.2. Description; 12.8.3. Microbe Type Portfolio; 12.8.4. Financials (Data as available in public domain and/or on paid databases); 12.8.5. Recent Developments; 12.9. Bon Vivant; 12.9.1. Overview; 12.9.2. Description; 12.9.3. Microbe Type Portfolio; 12.9.4. Financials (Data as available in public domain and/or on paid databases); 12.9.5. Recent Developments; 12.10. Standing Ovation; 12.10.1. Overview; 12.10.2. Description; 12.10.3. Microbe Type Portfolio; 12.10.4. Financials (Data as available in public domain and/or on paid databases); 12.10.5. Recent Developments
13. Strategic Recommendations
14. Appendix